Diabetes & Metabolism Journal

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus.

Dong Lim Kim

Diabetes Metab J. 2008;32(6):532-533. Published online December 1, 2008
DOI: https://doi.org/10.4093/kdj.2008.32.6.532

The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus (Korean Diabetes Journal 32(5):445-452, 2008)

Dong-Lim Kim

Korean Diabetes Journal. 2008;32(6):532

Link1 Link2 Link3

The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus

Tae Seo Sohn, Jee In Lee, In Ju Kim, Kyung Wan Min, Hyun Shik Son

Korean Diabetes Journal. 2008;32(5):445

Link1 Link2 Link3

Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

J. Rosenstock, J. Rood, A. Cobitz, N. Biswas, H. Chou, A. Garber

Diabetes, Obesity and Metabolism. 2006;8(6):650-660

Link1 Link2

Letter to the editor in reference to article titled: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

H. Pokharna, B. Kanna

Diabetes, Obesity and Metabolism. 2007;9(6):914-914

Link1 Link2

Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

A. Garber

Diabetes, Obesity and Metabolism. 2008;10(5):436-437

Link1 Link2

Triple Therapy in Type 2 Diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients

J.L. Leahy

Yearbook of Endocrinology. 2007;2007:66-69

Link1 Link2

Triple Therapy in Type 2 Diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients

J.L. Leahy

Yearbook of Medicine. 2007;2007:468-471

Link1 Link2

Evaluation of PRKAA2 Genetic Variation on Metformin Efficacy as an Initial Therapy Among Drug-Naïve Patients With Type II Diabetes Mellitus

Dita Virginia, Mae Wahyuningsih, Dwi Nugrahaningsih

. 2020;

Link1 Link2

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

C. Reasner, L. Olansky, T. L. Seck, D. E. Williams-Herman, M. Chen, L. Terranella, A. O. Johnson-Levonas, K. D. Kaufman, B. J. Goldstein

Diabetes, Obesity and Metabolism. 2011;13(7):644-652

Link1 Link2

Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients

Harold Bays

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2012;125

Link1